General Catalyst is a venture capital firm founded in 2000 that provides early-stage and growth equity investments in technology companies. It supports portfolio companies with momentum and mentorship to accelerate growth toward long-term success and typically engages across seed to growth stages, potentially taking minority or majority stakes. The firm targets a broad range of sectors enabled by software and technology, including consumer, enterprise, fintech, crypto, healthcare IT, and related areas, and maintains a multi-region presence with offices in North America and Europe to back companies as they scale globally.

OrbiMed is a healthcare-focused investment firm based in New York, founded in 1989, with approximately $5 billion in assets under management. It engages in private equity, venture capital, and growth investments across the global healthcare landscape, spanning biopharmaceuticals, biotechnology, life sciences tools, medical devices, diagnostics, health care services, and digital health. The firm invests across the development spectrum, from startup ventures to mature companies, and pursues opportunities worldwide, including North America, Europe, Asia, Israel and India, leveraging a long-standing specialization in the sector. Through its diversified capital programs, OrbiMed partners with management to advance innovative therapies, tools, and services that address significant medical needs.

SOSV is a global venture capital firm based in Princeton, New Jersey, founded in 1995, that focuses on seed to growth investments in deep technology across health, environmental tech, hardware, robotics, and cross border software, with a particular emphasis on Asia. The company runs accelerator style startup development programs, including HAX and IndieBio, which provide facilities, engineering resources, and lab equipment to help founders accelerate product development, acquire customers, and attract later stage funding. SOSV pursues a limited number of high potential startups, offering extensive hands on support to speed commercialization and scale, and aims to back innovations that improve human and planetary health.

Alumni Ventures Group is a venture capital firm based in Manchester, New Hampshire, established in 2013. It targets individual accredited investors who previously had limited access to venture capital by enabling alumni from top entrepreneurial schools to invest together in ventures led by fellow alumni. The firm backs companies with an alumni connection and an institutional lead investor with sector expertise. It offers focused funds that provide accredited investors access to a diversified venture portfolio by type, sector, stage, and geography. The organization engages in seed, early-stage, and late-stage pre-IPO investments across technology, consumer, financial services, health care, life sciences, and other sectors.

F-Prime Capital is a venture capital investment firm based in Cambridge, Massachusetts. Founded in 1969 with roots in Fidelity Investments, it backs entrepreneurs across technology and life sciences, investing in sectors such as crypto, enterprise information technology, fintech, frontier technologies, health information technology and services, medtech and therapeutics, with a global reach across the Americas, Europe and Asia.

Right Side Capital Management is a San Francisco-based venture capital firm founded in 2010 that invests in early-stage technology startups. It specializes in pre-seed and seed rounds for capital-efficient companies, with a focus on the United States and Canada and occasional activity in Western Europe, Israel, Australia, and New Zealand. The firm typically makes 75 to 100 investments per year, with round sizes from 50,000 to 500,000 and pre-money valuations ranging from 1,000,000 to 3,500,000. Portfolio companies are typically located outside the San Francisco Bay Area and New York City, and the firm aims to provide a clear yes or no on opportunities within about two weeks.

Deerfield Management is a New York-based investment management firm founded in 1994 that focuses on healthcare. It engages in long-term structured investments in both public and private healthcare companies, and operates across investment activities, information services, and philanthropy. It acts as an investment adviser and supports private and public investments across life sciences, medical devices, diagnostics, digital health, and health services.

StartUp Health is a health innovation platform founded in 2011 that supports a global portfolio of health technology companies through a network of entrepreneurs known as Health Transformers. Its mission is to achieve health moonshots by advancing solutions across Access to Care, Cost to Zero, Cure Disease, End to Cancer, Women’s Health, Children’s Health, Nutrition and Fitness, Brain Health, Mental Health and Happiness, Addiction, Longevity, and Pandemic Response. The organization oversees more than 330 portfolio companies across six continents and 26 countries, working with leading health systems and investors to accelerate adoption and impact. By connecting entrepreneurs with health systems, researchers, and investors, StartUp Health aims to improve the health and wellbeing of people worldwide and transform healthcare delivery over a multi-decade timeframe.

Andreessen Horowitz is a venture capital firm based in Menlo Park, California. Founded in 2009 by Marc Andreessen and Ben Horowitz, it funds software and technology companies across seed to growth stages, with emphasis on web and mobile applications, cloud infrastructure, enterprise software, fintech, consumer Internet, artificial intelligence, and biotech-adjacent ventures. The firm focuses on technology-enabled businesses and provides strategic support and networks to portfolio companies.

Antler is a global venture capital firm based in Singapore that backs early-stage technology companies. It runs incubation programs and provides a global community of co-founders, access to talent, expert advisors, expansion support, and capital to help startups grow. The firm targets a broad range of sectors, including healthcare, finance, software, energy, consumer and B2B technologies, and operates through regional programs across Europe, the United States, the United Kingdom, Southeast Asia, India, Africa, and beyond.

New Enterprise Associates is a U.S.-based venture capital firm founded in 1977 and headquartered in Menlo Park, California. It invests in technology and healthcare companies across stages and geographies, supporting startups from seed to growth. The firm operates globally with investments in the United States, Asia, and Brazil among others, and has a long track record of portfolio IPOs and acquisitions. It has over $19 billion in cumulative committed capital.

Oak HC/FT is a Stamford, Connecticut-based venture and growth equity firm that concentrates on healthcare information services and financial technology. It supports entrepreneurs with strategic counsel, board‑level participation, and access to an extensive network of industry leaders to drive transformation in these sectors. The firm draws on Oak Investment Partners’ sector expertise to build and grow innovative businesses, with a history of notable exits and large valuations. Founded in 2014, Oak HC/FT targets both growth‑stage and early‑stage companies in the United States, aiming to deliver strong value for investors.

Qiming Venture Partners is a China-based venture capital firm founded in 2006, with offices in Shanghai, Beijing, Suzhou, Hong Kong, and Singapore. It manages USD and RMB funds totaling about 9.5 billion in capital and backs early- and growth-stage technology, consumer, and healthcare companies. The firm has backed more than 530 portfolio companies, with over 200 exits via IPOs or M&A, and more than 70 unicorn or super unicorn companies.

Frist Cressey Ventures is a Nashville-based venture capital firm focused on healthcare and digital health. Founded in the mid-2010s, it makes early- and growth-stage investments in technology and service businesses that offer viable solutions to improve quality of care, system integration, patient outcomes, and population health. The firm emphasizes value-added partnerships to accelerate growth and scale within the healthcare sector.

Novo Nordisk is a global healthcare company that develops, manufactures, and distributes insulin and other diabetes medicines to treat chronic diseases. It pursues scientific breakthroughs and aims to expand access to its medicines, with the ultimate goal of preventing and curing disease.

Flare Capital Partners is a Boston-based venture capital firm focused on healthcare technology and related life sciences. It invests in early-stage and growth companies across the United States, targeting healthcare technology systems, digital health, big data and analytics, medical devices, diagnostics, and other health care innovations that enable value-based care and data-driven patient outcomes.

Khosla Ventures is a California-based venture capital firm founded in 2004 by Vinod Khosla. The firm backs entrepreneurs with venture assistance, strategic guidance, and capital, focusing on bold, early-stage technology companies. It invests across sectors including AI, climate and sustainability, enterprise software, consumer technologies, fintech, digital health, medtech and diagnostics, therapeutics, and frontier technologies. Based in Menlo Park, the firm manages several funds to support startups across stages, prioritizing ventures that address large markets and have potential for significant social and economic impact.

Established in 2020, the European Innovation Council supports innovative startups and researchers with promising ideas, focusing on early-stage companies with positive environmental, social, or governance impacts. It co-invests alongside private investors.

RA Capital Management is a Boston-based investment firm that specializes in life sciences and healthcare companies. The firm provides investment management and venture capital services, backing companies developing drugs, medical devices, diagnostics, and biotech tools. Its team combines expertise in biology, chemistry, and medicine with industry and business development experience. RA Capital supports companies across multiple stages, from seed funding to growth financings, including private and public rounds, and often takes board seats and seeks co-investment opportunities. Through its activity, it aims to identify technologies with potential to advance prevention and treatment, genetic testing and personalized medicine, and other patient-focused innovations.

SMBC Venture Capital is the corporate venture capital arm of Sumitomo Mitsui Banking Corporation. Founded in 2005 and headquartered in Tokyo, with an office in Osaka, the firm invests in growth capital and buyouts across multiple sectors. It targets information technology, life sciences, services, and manufacturing, supporting portfolio companies with strategic value and access to SMBC's network and resources.

Bossa Invest is a venture capital firm based in Sao Paulo, Brazil, founded in 2011, that manages investment portfolios and provides asset management services to clients across sectors, with a focus on software as a service companies, and analyzes market trends to inform its investment decisions while operating in finance, technology, and real estate.

Morningside is a Boston-based investment firm founded in 1986 as a family office for the Chan family. It makes venture capital investments in companies with novel science and technology, with deep expertise in life sciences, digital health, artificial intelligence, materials, and technology. The firm takes a long-term approach to building companies and emphasizes ethical conduct. In addition to its investment activities, Morningside supports charitable initiatives in education, research and healthcare, including collaborations with Harvard T.H. Chan School of Public Health, UMass Chan Medical School, and the MIT Morningside Academy for Design.

Jumpstart Foundry is a venture capital firm and accelerator based in Nashville, Tennessee, that funds and supports early-stage healthcare companies. It connects portfolio startups with industry stakeholders and provides guidance on strategic marketing, talent and growth, while operating a 14-week core program and a six-week micro-accelerator for startups, as well as a corporate-focused micro-accelerator. The firm concentrates on healthcare information technology, consumer health products and services, tech-enabled services, and diagnostic devices in the United States, aiming to accelerate growth, market adoption, and collaboration with industry leaders.

Eli Lilly is a global pharmaceutical company that discovers, develops, manufactures, and sells medicines across neuroscience, cardiometabolic diseases, cancer, and immunology. It operates manufacturing and research facilities in the United States, Puerto Rico, and about 25 other countries, with products sold in roughly 135 countries. The portfolio includes Verzenio, Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, Humulin, Taltz, and Olumiant, reflecting a diversified, science‑driven approach. In addition to human medicines, Lilly conducts research in animal health to treat animal diseases and support agricultural productivity. The company maintains a strong emphasis on research and development to address unmet medical needs and to bring innovative therapies to patients worldwide.

Echo Health Ventures is a venture capital firm based in Seattle, Washington, founded in 2016, with offices in Durham, Portland, and Seattle. It invests in healthcare, health technology, insurance technology, and digital health companies across the United States. As a stage-agnostic investor, it aims to accelerate portfolio companies' innovations and help them scale nationally, offering more than capital through deep, high-value relationships and strategic support.

Ben Franklin Technology Partners of Southeastern Pennsylvania is a non-profit organization founded in 1982 that supports the region's technology ecosystem. Based in Philadelphia, it acts as a capital provider and catalyst for early-stage and growing technology companies across information technology, health, and physical sciences by offering seed-stage funding and related resources to accelerate commercialization. The organization facilitates university–industry partnerships and regional initiatives that connect scientific research with market opportunities, with the aim of creating jobs and strengthening entrepreneurial communities in Southeastern Pennsylvania. Through its programs and partnerships, it supports adoption of new technologies and helps build a robust regional innovation ecosystem.

Gaingels is a venture investment organization focused on LGBTQ+-founded and led companies and their allies, investing across stages from pre-seed to pre-IPO and maintaining a global portfolio. Founded in 2014 and based in New York, it operates as a syndicate with more than 130 portfolio companies and around $70 million deployed. The organization supports inclusive leadership by backing ventures that promote diverse C-suite and board representation and actively assists portfolio companies in recruiting diverse executive talent. It also fosters a global community of industry leaders, investors, operators, and entrepreneurs who pursue positive social change through business and successful investments.

FJ Labs is a New York-based venture capital firm founded in 2015 by Fabrice Grinda. It is stage-agnostic and focuses on marketplaces and consumer-facing startups, making seed and Series A investments. Typical checks range from 50,000 to 5,000,000 dollars. The firm supports early-stage companies across sectors such as e-commerce, fintech, ad tech, mobile, and software-as-a-service, seeking opportunities with high growth potential in the United States and internationally. Its portfolio includes a mix of consumer brands and marketplace platforms, reflecting an emphasis on business models that connect buyers and sellers or enable direct consumer experiences. FJ Labs aims to back entrepreneurs building scalable, disruptively positioned products and services, often partnering with founders early in their development to help accelerate growth.

BoxGroup is a New York-based venture capital firm that backs early-stage technology startups, typically investing in pre-seed to Series A rounds. It supports companies across consumer, enterprise, fintech, healthcare, life sciences, marketplaces, and related sectors, prioritizing teams with strong vision and momentum. The firm seeks entrepreneurs launching movements in existing markets or creating new ones and aims to help category-defining businesses at the outset. While geographically active in major innovation hubs, BoxGroup evaluates opportunities across the United States and beyond, with a preference for early involvement and smaller initial checks.

Vivo Capital is a healthcare-focused investment firm founded in 1996 and headquartered in Palo Alto, California, with offices in Asia. The firm operates a multi-strategy platform including growth equity, private equity, venture capital, and public equity, and invests across biopharmaceuticals, specialty pharmaceuticals, medical devices, diagnostics, and healthcare services. It pursues opportunities globally, including the United States and China, and has invested in more than 290 companies. The team comprises physicians, scientists, entrepreneurs, operating executives, and industry experts, and the firm manages about $5.8 billion in assets.

Global Founders Capital is a Berlin, Germany-based venture capital firm with a global focus that invests across seed, early, and later-stage companies. It maintains a stage-agnostic approach, seeking innovative ideas with potential impact and feasibility in global markets.

Founders Fund is a San Francisco-based venture capital firm that backs science and technology companies across stages. The firm focuses on transformational technologies and has supported early backers of SpaceX, Palantir, Facebook, and Airbnb. It pursues a founder-friendly approach that provides significant support with minimal interference, and it invests globally across sectors including software, artificial intelligence, aerospace, energy, healthcare, cybersecurity, biotech, and information technology. The firm targets opportunities from seed to growth stages and emphasizes solving difficult problems through innovative technology.

Sequoia Capital is a venture capital firm founded in 1972 and based in Menlo Park, California. It pursues investments across multiple sectors, including information technology, healthcare, manufacturing, mobile, nanotechnology, financial services, internet, energy, media, and retail, and provides early to growth-stage funding coupled with strategic support to help founders build lasting, category-defining companies.

Optum is a health services and innovation company dedicated to helping people live healthier lives. It designs a healthcare system that connects people, places, and ideas across the ecosystem to deliver personalized care, including medication, healthcare financial services, and guidance, along with technology and services for health plan providers. The company offers a broad range of medical services, including family medicine, internal medicine, pediatrics, women's health, substance use treatment, and mental health, as well as care for common conditions of the eyes, ears, skin, and nervous system. By integrating data, insights, and digital tools, Optum seeks to improve access, care coordination, and the efficiency of the medical system for patients, providers, and employers in collaboration with health plans and other partners.

HealthTech Capital is a private investor group that funds and mentors healthtech startups at the intersection of healthcare, computing, and mobility. The group aims to foster an ecosystem by connecting clinical providers, venture firms, and other strategic industry players to support healthtech innovation. Founded in 2010 and based in Los Altos Hills, California, it operates as an angel group investing in healthtech startups.

Heritage Group is a Nashville, Tennessee-based private equity and venture capital firm founded in 1986. It focuses on healthcare and related technology sectors, including healthcare services and health IT, and invests across early-stage and growth opportunities. The firm typically makes investments up to $15 million and often assumes board seats to help guide strategic and operational development in its portfolio companies.

Mission BioCapital is a life science venture capital firm that backs early‑stage biotechnology companies. Based in Cambridge, Massachusetts, the firm draws on a leadership team with a long history of investing in and launching numerous early‑stage life science ventures. It operates in regions with strong research, discovery, and venture capital ecosystems and is known for providing deep expertise and active support to its portfolio companies.

Bessemer Venture Partners is a global venture capital firm founded in 1911 and headquartered in Redwood City, California. It backs startups across seed to growth stages, focusing on software, cloud, cybersecurity, fintech, consumer and healthcare technologies, and high-growth business models. The firm operates internationally, supporting portfolio companies from early product development through scale, and has backed well-known names such as Pinterest, Shopify, Twilio, Yelp, LinkedIn, Wix and others. BVP emphasizes helping founders establish durable foundations and guides companies through multiple growth phases, leveraging hands-on operational support, strategic networks, and cross-border expertise. With a diversified approach that includes consumer, enterprise and deep-tech investments, the firm seeks to build lasting companies that matter across global markets.

Versant Ventures is a healthcare-focused venture capital firm founded in 1999 and based in San Francisco, with offices in Canada, the United States and Europe. The firm invests across the healthcare sector at all stages, with an emphasis on discovery and development of novel therapeutics, and portfolios spanning biotechnology, pharmaceuticals, life sciences, healthcare devices and healthtech. Versant combines deep investment, operating and scientific expertise to support entrepreneurs through hands-on company building. It has backed more than 65 portfolio companies that have achieved acquisitions or IPOs.

Liquid 2 Ventures is a San Francisco, California-based venture capital firm that provides seed-stage and early-stage investments to technology startups. Founded in 2015 by Joe Montana, Mike Miller, and Michael Ma, the firm focuses on technology companies across software, telecommunications, media, and other TMT sectors, offering early funding and strategic guidance to its portfolio companies.

LRVHealth is a Boston, Massachusetts-based venture capital firm founded in 2000 that concentrates on technology and healthcare investments. The firm targets software, healthcare technology, digital health, healthcare information technology, medical devices, diagnostics, and related technology-enabled services, supporting seed through growth-stage companies. It typically makes minority investments, often partnering with other investors, and prefers to invest roughly between $0.5 million and $5 million. LRVHealth draws on a network of provider, payer, and vendor organizations to source opportunities and help portfolio companies adopt innovative solutions across the healthcare industry. The firm maintains offices in Boston and additional Massachusetts locations to support its operations.

Service Provider Capital is a Colorado-based venture capital firm founded in 2014 that funds seed-stage technology companies across domains such as artificial intelligence, machine learning, blockchain, cybersecurity, fintech, e-commerce, education technology, hardware, robotics, information technology, health tech, and cannabis. The firm also co-invests in Series A rounds led by institutional venture funds, providing capital and guidance to startups in the United States, including the Midwest and Southeast regions.

First Round Capital is a San Francisco-based seed-stage venture capital firm that backs technology startups from pre-seed through Series A. It offers capital, a founder-focused community, and services designed to help companies grow from inception, with partners who take an active role in portfolio companies. The firm invests nationally across sectors including healthcare, consumer technology, fintech, hardware, artificial intelligence, and web3, with offices in San Francisco and New York. It emphasizes resources beyond funding and has adopted a diversity term sheet rider to promote inclusive entrepreneurship.

Town Hall Ventures is a New York-based venture capital firm founded in 2018 that backs healthcare technology companies across the United States. It seeks to transform the U.S. health care system by partnering with entrepreneurs who aim to improve care delivery and health outcomes for underserved and high-need populations through technology-enabled solutions.

Joyance Partners is a San Francisco-based venture capital firm that backs early-stage startups in technology, health tech, consumer, internet, and mobile sectors across North America, Europe, and Asia. Founded in 2012, the firm seeks companies that, through science and technology, cultivate joy and improve how people live, with emphasis on health and consumer applications from pre-seed to Series A.

Polaris Partners is a Boston-based venture capital firm with offices in Boston and San Francisco that backs technology and life sciences companies across the United States and Europe. Founded in 1996, the firm partners with repeat entrepreneurs to support companies through multiple stages, from inception to growth, with a focus on software, healthcare information technology, digital health, life sciences, biotechnology, pharmaceuticals, genomics, and related sectors. Its investments span the business-to-business and business-to-consumer markets, software as a service, and other technology-enabled solutions, aiming to build durable platform companies and address significant needs in healthcare and technology.

ARCH Venture Partners is a United States-based venture capital firm founded in 1986 and headquartered in Chicago, Illinois. The firm focuses on science-driven companies, with a track record of commercializing technologies developed at academic research institutions and national laboratories. It primarily invests in life sciences, biotechnology, pharmaceuticals, healthcare technology, and related sectors, and also backs software, materials, clean tech, and information technology across early to growth stages. ARCH emphasizes relationships with scientists and entrepreneurs, often taking early stakes and supporting subsequent rounds to help market entry and scale. The firm has raised multiple venture funds totaling several billion dollars and maintains a national and international reach with offices across North America.

Providence Health & Services is a non-profit Catholic health system operating hospitals and a broad network of health care facilities across Alaska, California, Montana, Oregon and Washington. It provides acute care, physician clinics, long-term and assisted living, palliative and hospice care, home health, supportive housing and education, supported by a large workforce of caregivers. The system emphasizes serving poor and vulnerable communities and delivers comprehensive care from birth through end of life.

City Light Capital is a New York-based venture capital firm founded in 2004 that conducts early- and growth-stage investments in United States companies. It backs teams building category-defining solutions across education, safety and care, and the environment, as well as technology-enabled sectors such as digital health, climate, energy, agriculture, and IoT. The firm pursues impact-oriented investments designed to scale revenue and improve lives by partnering with experienced entrepreneurs to build durable, market-leading businesses. City Light emphasizes aligning financial returns with social and environmental outcomes and acts as an active, hands-on investor across a broad range of sectors addressing societal challenges.

Lux Capital is a venture capital firm based in New York City and Silicon Valley that funds seed- and early-stage technology and science startups. It concentrates on deep tech across the physical and life sciences, investing in biochemistry, material science, electronics, infrastructure, aerospace, satellites, drones, and space technologies, as well as software, machine learning, and artificial intelligence, genomics and synthetic biology. The firm takes an active role in helping entrepreneurs build high-growth companies and has a track record of launching more than 20 portfolio companies. With a technically engaged approach, Lux supports portfolio progress by leveraging deep domain insight and industry connections to drive leadership and scale.